Vibha Ravi
@scripvibha
Senior Editor, Citeline - Scrip, Pink Sheet. Tweets on pharma, health, environment, other topics of interest to those who read beyond headlines, social media
You might like
As US companies increase DTC advertising and FDA gets into scrutiny mode, how can pharma "shift left” with agentic AI, balance compliance and creativity? #regulatory #Marketing #biotech @indegeneinsight insights.citeline.com/pink-sheet/com…
Cipla to acquire Inzpera, Indian maker of pediatric pharma and wellness products for INR1.1bn #acquisition #deals #pharma bseindia.com/xml-data/corpf…
ESMO: Lupin’s STING Agonist Signals Safety; Will It Find Partners? #research #ESMO2025 #oncology #biotech insights.citeline.com//scrip/confere…
Does Lupin’s Proposed $250m Coral Springs, US Site Spell The Beginning Of An Indian Wave Of Fresh Manufacturing Investments? #Tariffs #India #BusinessGrowth #Biotechnology insights.citeline.com//scrip/busines…
Sakaguchi’s Nobel Brings Cheer To Japan Biopharma — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/49ni5 vist.ly/49ni6
Lupin strengthens global specialty portfolio with €190m VISAfarma acquisition in Europe #acquisition #deals #pharmaceuticals
Trump: 100% tariff on any branded or patented pharma product unless manufacturing plant being built in the US. "Branded" definition needed before further comment. Wrote this before the announcement #tariff #BusinessNews #pharmatariff #Biotech insights.citeline.com//pink-sheet/ma…
The Rise In China Deals: How International Biopharma Is Turning To China For Innovation — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/46n39 vist.ly/46n3a
Under new owner Bain Capital, the Japanese firm is aiming to regain its global presence, helped by new top executives formerly with Pfizer Japan and Takeda. insights.citeline.com//scrip/focus-o…
Multiple Korean ministries, biopharma companies, and other officials convened at a bio innovation roundtable to discuss strategies to emerge as a global biopharma powerhouse, @PharmaPinkSheet reports. insights.citeline.com/pink-sheet/r-a…
Zydus Beats Gilead, Ipsen On Cholangitis Primary Endpoint But Which Factors Are Key To Success? #Zydus #PharmaceuticalCompanies #business #research $GILD $IPN insights.citeline.com//scrip/r-and-d…
China NHSA Releases Preliminary Innovative Drug List For First Time — Click image below to read more! || #PinkSheet | Start your free trial today: vist.ly/44prp vist.ly/44prq
Sumitomo Pharma's iPSC therapy for Parkinson's has been filed for approval in Japan and may become one of the first such therapies to reach the market in the country, which has invested heavily in the modality. insights.citeline.com//scrip/advance…
In this episode: Madrigal regains MASH lead with EU Rezdiffra approval; Viking’s obesity data scare investors; China assets lead GLP-1 deals; CSL and others restructure; and Indegene exec on DTP and MFN policies.
Quick Listen: Scrip’s Five Must-Know Things — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/44f7t vist.ly/44f7u
50% Levy On India And Brazil, US Tariffs Leave Global Trade, Forecasts In Disarray. This is what we had said. Now 50% tariffs come into effect from Aug. 27 as US Customs issues notice #TariffsOnIndia #Tariffs #TradeWar #BusinessStrategy insights.citeline.com//pink-sheet/ma…
An interview with OneSource CEO, MD Neeraj Sharma reveals he isn't just counting on semaglutide (Novo's Wegovy, Ozempic) but is talking to next-gen GLP-1 innovators for growth #BusinessNews #Strategy @strides_pharma insights.citeline.com//scrip/leaders…
Quick Listen: Scrip’s Five Must-Know Things — Click image below to read more! || #Scrip | Start your free trial today: vist.ly/43nvi vist.ly/43nvj
Always great to have a vote of confidence from a person you look up to. Thanks @ScripIanHaydock
Excellent data- and infographics-supported analysis of the impact of #tariffs on #pharma in India and beyond by @scripvibha for @PharmaPinkSheet
Quick Listen: Scrip’s Five Must-Know Things insights.citeline.com//scrip/podcast…
Why does Aurobindo expect US-based Lannett's acquisition to pass FTC scrutiny? How does it help to reduce tariffs? Read to know #business #Tariffs #Acquisition insights.citeline.com//scrip/busines…
United States Trends
- 1. Sunderland 126K posts
- 2. Arsenal 220K posts
- 3. St. John 7,117 posts
- 4. Texas Tech 10.8K posts
- 5. Jeremiah Smith 2,009 posts
- 6. #SUNARS 12.5K posts
- 7. Philon 1,590 posts
- 8. #GoDawgs 3,895 posts
- 9. #iufb 1,527 posts
- 10. Raya 25.2K posts
- 11. Trossard 19.5K posts
- 12. Gus Johnson N/A
- 13. Charlie Becker N/A
- 14. Carnell Tate N/A
- 15. Noah Thomas N/A
- 16. Mendoza 8,453 posts
- 17. Shapen N/A
- 18. Nate Frazier N/A
- 19. Mississippi State 4,197 posts
- 20. Saka 35.5K posts
You might like
-
Anju Ghangurde
@scripanjug -
Ian Haydock
@ScripIanHaydock -
Vikas Dandekar
@VikasReports -
NPPA~India🇮🇳
@nppa_india -
Scrip, Citeline Commercial
@PharmaScrip -
Rupali Mukherjee
@Rupalijee -
Pam Belluck
@PamBelluck -
The Pharma Letter
@ThePharmaLetter -
Medtech Insight, Citeline Commercial
@Medtech_Insight -
PharmaCompass
@pharmacompass -
BioCentury
@BioCentury -
Salil
@salilkallianpur -
Bob Herman
@bobjherman -
Teena Thacker
@Teensthack -
cafepharma
@cafepharma
Something went wrong.
Something went wrong.